IRF5 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, recently it was demonstrated that IRF5 is a target of the oncogene BCR-ABL kinase and restoration of IRF5 expression reduces Chronic myeloid leukemia (CML) cell proliferation (176).